These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16111092)

  • 1. Reducing the incidence and severity of post ERCP pancreatitis.
    Murray WR
    Scand J Surg; 2005; 94(2):112-6. PubMed ID: 16111092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study.
    Ito K; Fujita N; Kanno A; Matsubayashi H; Okaniwa S; Nakahara K; Suzuki K; Enohara R;
    Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
    Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
    Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Freeman ML
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1354-65. PubMed ID: 17981248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events: post-ERCP pancreatitis.
    Rustagi T; Jamidar PA
    Gastrointest Endosc Clin N Am; 2015 Jan; 25(1):107-21. PubMed ID: 25442962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing post-ERCP pancreatitis: where are we?
    Testoni PA
    JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis.
    Tarnasky P; Cunningham J; Cotton P; Hoffman B; Palesch Y; Freeman J; Curry N; Hawes R
    Endoscopy; 1997 May; 29(4):252-7. PubMed ID: 9255527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-ERCP pancreatitis: review of current preventive strategies.
    Feurer ME; Adler DG
    Curr Opin Gastroenterol; 2012 May; 28(3):280-6. PubMed ID: 22450899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.
    Das A; Singh P; Sivak MV; Chak A
    Gastrointest Endosc; 2007 Jun; 65(7):960-8. PubMed ID: 17331513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results.
    Saad AM; Fogel EL; McHenry L; Watkins JL; Sherman S; Lazzell-Pannell L; Lehman GA
    Gastrointest Endosc; 2008 Feb; 67(2):255-61. PubMed ID: 18028920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.
    Fogel EL; Eversman D; Jamidar P; Sherman S; Lehman GA
    Endoscopy; 2002 Apr; 34(4):280-5. PubMed ID: 11932782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
    Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
    Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study.
    Yaghoobi M; Pauls Q; Durkalski V; Romagnuolo J; Fogel EL; Tarnasky PR; Aliperti G; Freeman ML; Kozarek RA; Jamidar PA; Wilcox CM; Elta GH; Hawes RH; Wood-Williams A; Cotton PB
    Endoscopy; 2015 Oct; 47(10):884-90. PubMed ID: 26165739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.
    Fazel A; Quadri A; Catalano MF; Meyerson SM; Geenen JE
    Gastrointest Endosc; 2003 Mar; 57(3):291-4. PubMed ID: 12612504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.
    Takenaka M; Fujita T; Sugiyama D; Masuda A; Shiomi H; Sugimoto M; Sanuki T; Hayakumo T; Azuma T; Kutsumi H
    J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):275-80. PubMed ID: 24039185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done?
    Hauser G; Milosevic M; Stimac D; Zerem E; Jovanović P; Blazevic I
    World J Gastroenterol; 2015 Jan; 21(4):1069-80. PubMed ID: 25632179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM; Abraham O; Huang R; Barth BA
    Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCP and prophylactic pancreatic stents: raising the bar, reducing the pain.
    Silverman WB
    Gastrointest Endosc; 2007 Jun; 65(7):969-70. PubMed ID: 17531629
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
    Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
    Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.